Active Not RecruitingNot applicableNCT04968548

Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening

This study is part of the development and validation of a non-invasive lung screening test which aim to identify early stage lung cancer in patients at high risk for lung cancer.

Checked against the public recordLast updated Nov 4, 2025 · Source: ClinicalTrials.gov

StatusActive Not Recruiting
PhaseNot applicable
U.S. locations31
SponsorNucleix Ltd.
01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Nucleix Ltd.
Interventions being studied
Procedure: Blood collection
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria - Cases: * Current or past smokers, with at least 20 pack-years * Subjects with either A high suspicion for lung cancer, with planned surgery to establish a definitive diagnosis within 60 days after date of blood collection OR treatment naive lung cancer patients Exclusion Criteria - Cases: * Known diagnosis or treatment of any previous cancer, including lung cancer, in the past 5 years, except for fully resected non-melanoma skin cancer or fully-resected carcinoma in situ of the cervix * Current lung cancer is known to be stage III or IV by pathology. Inclusion Criteria - Screening: \- Current or past smokers, with at least 20 pack-years, undergoing LDCT for lung cancer screening Exclusion Criteria - Screening: * Known diagnosis or treatment of any cancer, including lung cancer, in the past 5 years, except for fully resected non-melanoma skin cancer or fully-resected carcinoma in situ of the cervix * Subjects whose purpose of performing LDCT is for surveillance of a lung nodule

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Scripps Memorial HospitalEncinitas, California
  • Centura HealthLakewood, Colorado
  • VA Connecticut Healthcare SystemWest Haven, Connecticut
  • Orlando Health, Inc.Orlando, Florida
  • Sarasota Memorial HospitalSarasota, Florida
  • St. Elizabeth Edgewood HospitalEdgewood, Kentucky
  • Norton Cancer InstituteLouisville, Kentucky
  • Owensboro HealthOwensboro, Kentucky
  • Johns Hopkins Medical CenterBaltimore, Maryland
  • Lahey Hospital and Medical CenterBurlington, Massachusetts
  • University of Minnesota HealthMinneapolis, Minnesota
  • Harry S. Truman Memorial Veterans' HospitalColumbia, Missouri

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 4, 2025. Always confirm current availability with the study team.

View original record ↗